Pharmafile Logo
Pharmafocus logo
Advanced Search
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

News
merckwindow_web

MSD to launch Keytruda at half US list price in China

September 20, 2018
Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing

US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …

News
almirall-605x338

Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis

September 19, 2018
Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis

Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …

News
kymriah

NICE rejects CAR-T therapy Kymriah for DLBCL in adults

September 19, 2018
Research and Development CAR T, CAR-T, Kymriah, NICE, Novartis, leukaemia

The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with …

News

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018
Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …

News
astrazeneca_plaque

AstraZeneca to increase presence in China

September 19, 2018
Research and Development AstraZeneca, China, alibaba, governemnt, tencent

The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …

News
5204602349_c87b204860_z

FDA expand REMS education program in effort against opioid crisis

September 19, 2018
Research and Development FDA, IR, opioid crisis, opioids, rems

The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training …

News
cruk

Cancer Research UK announces new £14m research hub in London

September 18, 2018
Manufacturing and Production, Research and Development CRUK, Cancer, pharma

Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …

News

Rates of vaccination decline in England, study shows

September 18, 2018
Manufacturing and Production England, NHS, health, public health, vaccines, vacinnation

The number of people who are receiving the 12 routine childhood vaccinations has declined in proportion to the eligible population …

News

US Senate pass bipartisan bill to tackle opioid crisis

September 18, 2018
Manufacturing and Production Senate, US, epidemic, opioid, opioid crisis, politics

The US Senate have passed a bipartisan bill aimed at combatting the opioid crisis. The bill, which was passed with …

News

US House of Representatives blocks drug pricing advert bill

September 18, 2018
Manufacturing and Production Big Pharma, Drug pricing, HHS, Trump, Twitter, adverts

A ruling which would force pharmaceutical companies to disclose the price of their drugs in television advertisements has been set …

News
novo_nordisk_flag

400 jobs to go as Novo Nordisk overhauls R&D operations

September 18, 2018
Manufacturing and Production, Sales and Marketing Novo Nordisk, pharma

Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of …

News

Sanofi’s Dupixent improves symptoms for adolescent atopic dermatitis patients

September 17, 2018
Research and Development, Sales and Marketing Dupixent, EADV 2018, Sanofi, atopic dermatitis, pharma

Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic …

News
astrazeneca_plaque

FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL)

September 17, 2018
Sales and Marketing AstraZeneca, HCL, Lumoxiti, leukaemia, rare diseases

AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who …

News
allergan

Allergan acquires neurotoxin specialist Bonti in $195m deal

September 17, 2018
Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …

News
teva_copy

Teva shares soar after migraine treatment Ajovy approval

September 17, 2018
Sales and Marketing FDA, Teva, US, ajovy, approval, israel

Shares in the Israeli pharma firm Teva soared on Sunday after the announcement that the US Food and Drug Administration …

News

NICE recommends Novartis combo as first-ever BRAF-targeted therapy for advanced post-surgery melanoma

September 17, 2018
Sales and Marketing Cancer, NICE, Novartis, Tafinlar, mekinist, melanoma, pharma

NICE has taken the decision to recommend the first ever first BRAF-targeted therapy for use on the NHS in England …

News
georg-terstappen

Ex-GSK R&D head joins OxStem as CSO

September 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, OxStem, University of Oxford

OxStem, a regenerative drug discovery unit spun out from the University of Oxford, has brought on board ex-GlaxoSmithKline R&D exec …

Appointment
manuel_aivado

Aileron Therapeutics name Dr Manuel Aivado as new President and CEO

September 14, 2018
Aileron, CEO, Massachusetts, Watertown, appointments

The Watertown Massachusetts-based stapled peptide therapeutics specialist Aileron Therapeutics has appointed former SVP, Chief Medical & Scientific Officer Dr Manuel …

Appointment

UCB brings promising plaque psoriasis data to EADV 2018

September 14, 2018
Medical Communications, Research and Development EADV 2018, UCB, pharma, psoriasis

UCB has joined in on the wave of new psoriasis data emerging from the European Academy of Dermatology and Venereology …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026